Nuvectis Pharma, Inc.
NVCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001875558
No open-market purchases or sales by Nuvectis Pharma, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $189.0M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Nuvectis Pharma, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −4 vs. Q2 2023
- Shares held
- 1.28M
- +24.4K (+1.9%) vs. Q2 2023
- Total value
- $16.5M
- −$3.57M (−17.8%) vs. Q2 2023
- New holders
- 1
- 14 more added
- Sold out
- 5
- 13 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $189.0M |
| Q1 2026 | 62 | $34.9M |
| Q4 2025 | 48 | $32.0M |
| Q3 2025 | 53 | $22.2M |
| Q2 2025 | 47 | $24.2M |
| Q1 2025 | 33 | $20.0M |
| Q4 2024 | 31 | $7.15M |
| Q3 2024 | 31 | $6.60M |
| Q2 2024 | 41 | $7.63M |
| Q1 2024 | 40 | $12.8M |
| Q4 2023 | 36 | $12.6M |
| Q3 2023 | 33 | $16.5M |
| Q2 2023 | 37 | $20.0M |
| Q1 2023 | 13 | $6.34M |
| Q4 2022 | 11 | $7.38M |
| Q3 2022 | 12 | $10.0M |
| Q2 2022 | 11 | $7.20M |
| Q1 2022 | 8 | $4.65M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Nuvectis Pharma, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 5 | $65 | 0.00% | −2,034−99.8% | Reduced |
| FMR LLC | 7 | $90 | 0.00% | −17−70.8% | Reduced |
| Hollencrest Capital Management | 280 | $3.61K | 0.00% | −2,760−90.8% | Reduced |
| Ameritas Investment Partners, Inc. | 566 | $7.30K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 841 | $10.8K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,039 | $13.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,088 | $14.0K | 0.00% | −1,604−59.6% | Reduced |
| Barclays PLC | 1,389 | $17.9K | 0.00% | +18+1.3% | Added |
| Dorsey Wright & Associates | 1,396 | $18.0K | 0.01% | −48−3.3% | Reduced |
| Wells Fargo & Company | 1,465 | $18.9K | 0.00% | −1,380−48.5% | Reduced |
| California State Teachers Retirement System | 1,641 | $21.2K | 0.00% | −638−28.0% | Reduced |
| Morgan Stanley | 3,479 | $44.8K | 0.00% | −1,624−31.8% | Reduced |
| American International Group, Inc. | 3,711 | $47.8K | 0.00% | +413+12.5% | Added |
| UBS Group AG | 3,776 | $48.7K | 0.00% | −203−5.1% | Reduced |
| STRS Ohio | 3,900 | $50.0K | 0.00% | +2,500+178.6% | Added |
| JPMorgan Chase & Co | 4,902 | $63.2K | 0.00% | −558−10.2% | Reduced |
| New York State Common Retirement Fund | 5,772 | $74.4K | 0.00% | +72+1.3% | Added |
| Bank of America Corp | 6,138 | $79.1K | 0.00% | +4,782+352.7% | Added |
| Rhumbline Advisers | 7,273 | $93.7K | 0.00% | +495+7.3% | Added |
| Tower Research Capital LLC (TRC) | 7,282 | $93.9K | 0.00% | +6,739+1,241.1% | Added |
| Nuveen Asset Management, LLC | 10,669 | $137.5K | 0.00% | 00.0% | Unchanged |
| Moran Wealth Management, LLC | 16,697 | $215.2K | 0.01% | +16,697 | New |
| Bank of New York Mellon Corp | 19,150 | $246.8K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 19,920 | $256.8K | 0.00% | +1,925+10.7% | Added |
| Renaissance Technologies LLC | 25,400 | $327.0K | 0.00% | −11,000−30.2% | Reduced |
| Forbes J M & Co LLP | 34,000 | $438.3K | 0.06% | −33,000−49.3% | Reduced |
| Marshall Wace, LLP | 36,085 | $465.1K | 0.00% | −5,690−13.6% | Reduced |
| Northern Trust Corp | 54,687 | $704.9K | 0.00% | +1,053+2.0% | Added |
| State Street Corp | 108,122 | $1.39M | 0.00% | +2,882+2.7% | Added |
| Baldwin Brothers Inc | 116,380 | $1.50M | 0.13% | +26,319+29.2% | Added |
| Geode Capital Management, LLC | 129,663 | $1.67M | 0.00% | +17,127+15.2% | Added |
| Vanguard Group Inc | 291,134 | $3.75M | 0.00% | +25,196+9.5% | Added |
| BlackRock Inc. | 359,447 | $4.63M | 0.00% | +44,956+14.3% | Added |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −28,028−100.0% | Sold out |
| Edmond de Rothschild Holding S.A. | 0 | $0 | 0.00% | −22,820−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −11,012−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −3,970−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −411−100.0% | Sold out |